| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.075 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |